News

The study showed in laboratory models that combination therapy with topotecan and carboplatin is superior to the standard triple-drug therapy using vincristine, carboplatin and etoposide. The new combination

The deal has been approved by the boards of directors of both companies and is expected to close in the fourth quarter of 2005, pending regulatory and other

FASgen’s novel small molecule compounds are designed to limit the appetite and to increase the metabolic breakdown of excess fat stored in the body. Studies in mice reveal

The product formulated utilizing the company’s proprietary TheraPlas delivery technology is composed of interleukin-12 (IL-12) gene expression plasmid and a biocompatible delivery polymer and is designed to increase

AZD-103 is part of a new class of therapeutics that provides significant advantages over the current products on the market which only treat disease symptoms. Strong preclinical data

Risperdal M-Tab is indicated for the treatment of schizophrenia, and the short-term treatment of acute manic or mixed episodes associated with bipolar disorder. The drug is made by

Approximately 25 patients suffering from late-stage head and neck cancer will be recruited for IRX Therapeutics’ phase II trial, involving clinical sites in the US and in Mexico.

Under the terms of the agreement, Merck will make an initial cash payment to Agensys of $17.5 million and, subject to the achievement of certain events, further payments

The research, which appears in the journal Nature, describes a method of deriving stem cells in mice using a technique of single-cell embryo biopsy similar to that used